INOVA is proud of our scientific prowess which is made evident by our numerous publications in peer reviewed scientfic journals. Please feel free to review the references below which are arranged by disease state.
Liver | Antiphospholipid Syndrome | Connective Tissue | Gastrointestinal | RA
Gabeta, S., Norman, GL, Liaskos, C, Papamichalis, PA, Zografos, T, Garagounis, A, Rigopoulou, EI, Dalekos, GN. Diagnostic relevance and clinical significance of the new enhanced performance M2 ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J. Clin. Immunology, 2007; 27(4): 378-387.
Montano-Loza A, Czaja AJ, Carpenter HA, Piette A, Murphy D, Shums Z, Burlingame R, Norman GL. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity 39: 341-8, 2006.
Nakamura, M, Takii, Y, Mori,T, Komori,A, Yokoyama,T, Daikoku, M, Matsumoto,T,Migita,K, Yatsuhashi,H, Ishibashi,H, Masaki,N, Adachi,H, Watanabe,Y, Nakamure,Y, Takezaki,E, Harada,H,Sando,T, Saoshiro,T, Komatsu,T, Shimada,M, Hayashi,S, Kobayashi,M, Sodeyama,T, Muro,T, Masumoto,A, Sugi,Kazuhiro, Lee, L, Shums, Z, Norman, GL. Anti-gp210 antibody in combination with anti-centromere antibody may identify PBC patients who are at high risk for end-stage hepatic failure. American Assn for the Study of Liver Disease , Annual Meeting San Francisco, 2005. Hepatol 2005; 42 (4 suppl 1) 463A.
Milkiewicz,P, Buwaneswaran, HB, Lee, L, Coltescu,C, Shums,Z. Norman,GL, Heathcote,EJ. Value of "new" autoantibody testing in the differential diagnosis of autoimmune liver conditions. American Assn for the Study of Liver Disease. Annual Meeting, San Francisco, 2205. Hepatol. 2005; 42(4 suppl 1) 292A.
Nakamura, M, Kondo, H, Mori, T, Komori, A, Matsuyama, M, Ito, M, Takii, Y, Koyabu, M, Yokoyama, T, Migita, K, Daikoku, M, Abiru, S, Yatsuhashi, H, Takezaki, E, Masaki, N, Sugi,K, Honda, K, Adachi, H, Nishi,H, Watanabe, Y, Nakamura, Y, Shimada, M, Komatsu,T, Saito, A, Saoshiro,T, Harada, H, Sodeyama, T, Hayashi, S, Masumoto,A, Sando,T, Yamamoto,T, Sakai,H,Kobayashi, M, Muro, T, Koga, M, Shums,Z, Norman, GL, Ishibashi,H. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007; Jan; 45(1):118-27. American Assn for the Study of Liver Disease (AASLD) Annual Meeting San Francisco 2005.
Czaja, AJ and Norman, GL. Autoantibodies in the Diagnosis of Liver Disease. J. Clin. Gastro. 2003, 37(4): 315-329.
Czaja, A.J., Shums, Z.,and Norman. G.L. Frequency and Significance of Antibodies to Soluble Liver Antigen/Liver Pancreas in Variant Autoimmune Hepatitis. Autoimmunity 35(8): 475-483, 2002.